Literature DB >> 187620

Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis.

F V Chisari, J A Routenberg, M Fiala, T S Edgington.   

Abstract

Defective T-lymphocyte E rosette (ER) function associated with viral hepatitis A and B may be due to mechanisms extrinsic or intrinsic to the target lymphocyte. The extrinsic defect is induced by an immunoregulatory plasma lipoprotein (RIF) and has the capacity to regenerate ER function in vitro. The intrinsic defect is refractory to regeneration and is not associated with RIF. Although both mechanisms occur with high frequency during the acute phase of viral hepatitis they tend to segregate in accordance with progression of hepatocellular injury at later stages of the disease. The extrinsic defect was observed in 7 out of 8 patients with longstanding chronic active hepatitis and in 10 out of 10 patients with unresolved hepatitis 12 wk after the onset of jaundice. In contrast, none of nine patients with resolved hepatitis had extrinsically defective ER function 12 wk after the onset of jaundice whereas eight of them displayed an intrinsic defect of ER function at that time. Among the various viral and liver diseases studied RIF appeared to be specific for hepatitis A and B viral infections. None of 64 sera from a variety of viral infections including Epstein-Barr virus cytomegalovirus mononucleosis with associated hepatitis nor 15 sera from patients with several chronic nonviral liver diseases were positive for RIF. RIF and its associated extrinsic defect in ER function therefore appear to correlate with a particular type of hepatocellular injury initiated by the hepatitis A and B viruses that may have a propensity for persistence and(or) progression to an aggressive form of chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 187620      PMCID: PMC333340          DOI: 10.1172/JCI108610

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  T and B lymphocytes in acute and chronic hepatitis.

Authors:  R J DeHoratius; R G Strickland; R C Williams
Journal:  Clin Immunol Immunopathol       Date:  1974-04

2.  Human T lymphocyte receptors for sheep erythrocytes: conditions for binding including inhibition by cytochalasin B.

Authors:  J H Kersey; D J Hom; P Buttrick
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

3.  Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction.

Authors:  Z Bentwich; S D Douglas; F P Siegal; H G Kunkel
Journal:  Clin Immunol Immunopathol       Date:  1973-07

4.  A lymphocyte-inhibiting factor isolated from normal human liver.

Authors:  K Schumacher; G Maerker-Alzer; U Wehmer
Journal:  Nature       Date:  1974-10-18       Impact factor: 49.962

5.  Influenza: response of T-cell lymphopenia to thymosin.

Authors:  M Scheinberg; N R Blacklow; A L Goldstein; T A Parrino; F B Rose; E S Cathcart
Journal:  N Engl J Med       Date:  1976-05-27       Impact factor: 91.245

6.  Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.

Authors:  F V Chisari; J A Routenberg; T S Edgington
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

7.  Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.

Authors:  R P Messner; F D Lindström; R C Williams
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

8.  Cell-mediated immunity in acute and chronic hepatitis.

Authors:  J R Wands; J L Perrotto; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

9.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

Authors:  J Wybran; H H Fudenberg
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Immunological functions of human T-lymphoid cell line (MOLT). I. Release of immunosuppressive factors from the mixture of MOLT-4 cells and sheep red blood cells.

Authors:  A Takada; Y Takada; J Minowada
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

View more
  7 in total

1.  Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. The significance of serum inhibition and rosette inhibitory factors.

Authors:  B Maisch; P Schuff-Werner; P A Berg; K Kochsiek
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

2.  Active E rosette-forming cells in the peripheral blood of patients with chronic active hepatitis.

Authors:  M C de Moura; F Ramalho
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

3.  Kinetics of peripheral blood leukocyte alterations in Thai children with dengue hemorrhagic fever.

Authors:  R A Wells; R M Scott; K Pavanand; V Sathitsathein; U Cheamudon; R P Macdermott
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

Review 4.  The immunopathology of acute type B hepatitis.

Authors:  L Bianchi
Journal:  Springer Semin Immunopathol       Date:  1981-04

5.  Antibodies directed against human liver specific membrane lipoprotein (LSP) in marmosets experimentally infected with the hepatitis A virus.

Authors:  D M Jensen; D A Peterson; L G Wolfe; T Hurley; J A Payne; J Ogden
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

6.  Inhibition of lymphocyte cytotoxicity by serum from patients with alcoholic liver disease: partial characterization of serum inhibitors.

Authors:  J R Wands; J L Dienstag
Journal:  Yale J Biol Med       Date:  1978 Nov-Dec

Review 7.  The immunopathogenesis of chronic HBV induced liver disease.

Authors:  G A Levy; F V Chisari
Journal:  Springer Semin Immunopathol       Date:  1981-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.